Asston Pharmaceuticals IPO Reservation
The Asston Pharmaceuticals IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 21,28,000 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
The Retail Individual Investor (RII) category has the highest allocation with 7,46,000 shares, representing 35.06% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 10,60,000 shares (49.81%), while Non-Institutional Investors (NIIs) receive 3,22,000 shares (15.13%).
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 1060000 | 49.81 | 0 |
| Non-Institutional | 322000 | 15.13 | 0 |
| Retail Investors | 746000 | 35.06 | 0 |
| Total | 2128000 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Asston Pharmaceuticals IPO?
The Retail Individual Investor (RII) quota in the Asston Pharmaceuticals IPO comprises 7,46,000 equity shares, representing 35.06% of the total IPO issue.
What is the reservation for QIBs in the Asston Pharmaceuticals IPO?
Qualified Institutional Buyers (QIBs) have been allocated 10,60,000 equity shares, representing 49.81% of the total IPO issue.
What is the reservation for HNI investors in the Asston Pharmaceuticals IPO?
The Non-Institutional Investors (NII) category has been allotted 3,22,000 equity shares (15.13%). This category is further divided into: Big HNI (bNII): - shares (%) Small HNI (sNII): - shares (%).
What is the category-wise reservation in the Asston Pharmaceuticals IPO?
The Asston Pharmaceuticals IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 10,60,000 shares (49.81%). Non-Institutional Investors (NII): 3,22,000 shares (15.13%). Retail Individual Investors (RII): 7,46,000 shares (35.06%).
Is there a shareholder quota in the Asston Pharmaceuticals IPO?
No. The Asston Pharmaceuticals IPO does not include a shareholder reservation.